retatrutide clinical trial status New Phase 3 data just dropped 👀 Eli Lilly's reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats When will Retatrutide be available

Seek urgent medical attention if thirst is accompanied by severe vomiting, persistent abdominal pain, rapid breathing, fruity-smelling breath, confusion, or signs of diabetic ketoacidosis

Bodybuilding or cosmetic use is a separate concern

The Lancet, 400(10366), 18691881.

The manufacturer of retatrutide, Lilly, has issued warnings to the public about the dangers of buying counterfeit medication

Discussion Weight loss reduces the risk of diabetes, and medications which reduce appetite can promote long-term weight loss [7]

It's approved for adults with obesity or adults with overweight and at least one weight-related medical condition